share_log

Oppenheimer Reiterates Outperform on BioVie, Maintains $12 Price Target

Benzinga ·  May 17, 2023 20:06

Oppenheimer analyst Jay Olson reiterates BioVie (NASDAQ:BIVI) with a Outperform and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment